{"name":"Verona Pharma plc","slug":"verona-pharma-plc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2024-01-01","label":"Ohtuvayre first approved","drug":"Ohtuvayre","drugSlug":"ensifentrine","type":"approval","sentiment":"positive"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Ensifentrine Dose 1","genericName":"Ensifentrine Dose 1","slug":"ensifentrine-dose-1","indication":"Cystic fibrosis","status":"phase_2"},{"name":"RPL554","genericName":"RPL554","slug":"rpl554","indication":"Other","status":"phase_2"}]},{"name":"Respiratory","slug":"respiratory","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Ohtuvayre","genericName":"ENSIFENTRINE","slug":"ensifentrine","indication":"chronic obstructive pulmonary disease (COPD)","status":"marketed"}]}],"pipeline":[{"name":"Ensifentrine Dose 1","genericName":"Ensifentrine Dose 1","slug":"ensifentrine-dose-1","phase":"phase_2","mechanism":"Ensifentrine is a dual inhibitor of the cystic fibrosis transmembrane conductance regulator (CFTR) and the epithelial sodium channel (ENaC).","indications":["Cystic fibrosis"],"catalyst":""},{"name":"Ohtuvayre","genericName":"ENSIFENTRINE","slug":"ensifentrine","phase":"marketed","mechanism":"Ohtuvayre works by blocking an enzyme called phosphodiesterase 3, which helps to increase the levels of a molecule called cyclic AMP in the lungs.","indications":["chronic obstructive pulmonary disease (COPD)"],"catalyst":""},{"name":"RPL554","genericName":"RPL554","slug":"rpl554","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0AJBVV95cUxPTWpXc3VzY3BHVkgtSzBYbE4zc2Rkenc4ZGNYUUZCenVDaEVXdGtYT1pEVWlsWjNmQnplMjNPQjdsaVRhOFdQUDN1eUdUTFQwZUxfOUIwa2NZdFJhZk5lQXZ0ZWpmQzkwY3lLb1dtSnQ2dGlWamJ2NTFhckFreFZNbmtyLXJ2T3lPeG0yMENQOFgxdEhobklMU2VHOVBLYUNyX01iVjRyOVdRZTM2WDB6MncwUk96aUM2TElVRmVDSWFpaTBIU1pXQWJWNUJCcXlsTHBwYmJXdUNDYVFPT09TeVBEaW1HZ0xqMG1MdlgxcF9YTVBRVEIyR3d3anRnTUptcGhsQktRazlzNk9HTmtTV2ZNMGNxOEw3QTR6QThFbDZUazBOekJlRlRmV3Z0b2h4ckdnYnlqMDFvU25rVVdRV1ZTaTFJVl9aZFdzOUEyM3M?oc=5","date":"2026-04-08","type":"pipeline","source":"Barchart.com","summary":"COPD Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Genentech, GlaxoSmithKline, Verona Pharma, Regeneron Pharma, Sanofi, MedImmune, EpiEndo Pharma, Tetherex Pharma, AstraZene","headline":"COPD Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Genentech, GlaxoSmithKline, Verona Pharma,","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNOEJOUWU2aWZhT01rU0E5NGNpN1pjVm5vcDRoN09wTjlnZXNEeFozODBpNFM3U3NxbkhrV1U1aElHNWJUSUJpY0o1el80T1o0ZzBGcTdPTnRPWWE5THhnTVk5Z1RUQ2YxMXd2QXlTeWp6Y2UwX1QyTTQwd0tVWVEtYXF3RTlhSEpjcWo2Mjl5MEVOak1uZ202RWx3?oc=5","date":"2025-10-09","type":"pipeline","source":"ROI-NJ","summary":"Merck announces $10B acquisition of Verona Pharma - ROI-NJ","headline":"Merck announces $10B acquisition of Verona Pharma - ROI","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPbGhmZnM5LUI3eVktOWt0eXRia0k3bkd5cW1PMGJqdFQzS3dhenV2MHM5dVJBbXVVMUxtWU5BT3hLeUdYMUFuRUtkRDZkRU9OMVpjUGFwT3lnaVlBbnJBVGVkUkFPTXpQTVl5VWFPc1RMUEUxQjZKZkkyOHRsbXRIRmpkLVZwQTJH?oc=5","date":"2025-10-08","type":"pipeline","source":"Yahoo Finance","summary":"Verona Pharma plc (VRNA)’s Shareholders Authorizes the $10 Billion Acquisition of Verona Pharma plc (VRNA); Nasdaq Trading to Suspend - Yahoo Finance","headline":"Verona Pharma plc (VRNA)’s Shareholders Authorizes the $10 Billion Acquisition of Verona Pharma plc (VRNA); Nasdaq Tradi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxOT084VS1UejV1emdsY29zallmaTg4N0hQZjFwTVd5amxGNFNrTDdmU1h0QTRxZzhkeFBTemtlMC01NjFPcHdPeDlXNlo3WElzWVBPNm1NYVJOZjhNSi1rNkZZc3hxb3l3WFFJd19RWUhadDkwaFdJTkNZRVl5MTdTUW9qUGhGaDBkMVBLUWxpS0UxVDJfWVllQzU4T1ZEUkFDWGtF?oc=5","date":"2025-10-07","type":"pipeline","source":"businesswire.com","summary":"Merck Completes Acquisition of Verona Pharma - businesswire.com","headline":"Merck Completes Acquisition of Verona Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPSTFsT2xKX1g5STI5QTAtTFJ2cmZ4V0RwSGhOenJmU3BlaTZkRWZTQTJDY2IwTEFrbkZmenV3U2pLLVRRaFFpejFlRDlXSm9raENReUNBQVJ2ZEp0cVpSVDBKQnNZX21rY0dlQnVJVWl5NWNBT3NybG1nWGtBcEFtdnVOdUp3YnN1b2hLZmVJQWNqUVB1?oc=5","date":"2025-10-07","type":"pipeline","source":"Contract Pharma","summary":"Merck Completes Acquisition of Verona Pharma - Contract Pharma","headline":"Merck Completes Acquisition of Verona Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQTmljMVhmcjlHOHRhVGtTQVpuTVlMSzVfSm91NW1JY29LWkcyMmw5MkJUdHhtSUNYRURiT2ZyR3c1d2p6YmZpRHRicnNra3VTY3VDSjhYT1B4S1pGcWNSLWVuTlVHN3dGXzhXSFFtTmhQRHhaeHNlQVluTEY2aDBlNzdCR2x4RU5FeDR2ZUNUSjhzUzVUdHU0ckctYThPVi1nWXBBb2tSVTdLTW1xdjItcmlSSVlBTkE?oc=5","date":"2025-10-06","type":"regulatory","source":"Investing.com","summary":"Court approves MSD’s $10 billion acquisition of Verona Pharma - Investing.com","headline":"Court approves MSD’s $10 billion acquisition of Verona Pharma","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTFBFV0kxOFBqMnVHeWVET3ltRTFmTVhSOVkzSl9HYjhuT0VGaE50bmF6R3EtRlJmTS1yOEJKV0h4OG1TWGRINm9Xd0VHMXV2Z3pNVEx3OFJuTnJ5S2I5Z1lsX1I4R0RRM2VJMFB1Y3drLXhsSk9FWlpoYzFwZ2VZUlE?oc=5","date":"2025-09-30","type":"deal","source":"Yahoo Finance","summary":"Verona Pharma plc (VRNA) Nears $10B Merck Buyout, Ohtuvayre Boosts COPD Portfolio - Yahoo Finance","headline":"Verona Pharma plc (VRNA) Nears $10B Merck Buyout, Ohtuvayre Boosts COPD Portfolio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE5jOVM0N3VtdEZuX2RPcEtrUEZ0ZDFfelhBX0tZWEZpbUlESkVfSWVTM1NFeEx2VXItTFloekpVQS0wRF9CSnpKMnp1WE5pbFpaMXBxNjNXSVFBS3RCb25ZQnQ3ZThuNVRhenM3NG1PXzhqY1ZnWHR3emVZMmE?oc=5","date":"2025-07-10","type":"deal","source":"Pharmaceutical Technology","summary":"Merck agrees to acquire Verona Pharma for $10bn - Pharmaceutical Technology","headline":"Merck agrees to acquire Verona Pharma for $10bn","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQS1JnZjllQmlPSVJJallZWWZlYmloRUlLaFFNMkRXTDFoaExMTmJBM2Y3cmhOOHhWd0o1WkxUM2NwbW9iRHZZMHNSRFdYZW5oXzd3OUhyVklEamNhNV81b29LWlU3d3ZwTC0zYjE4dGFqMVIwNXE1RTVicjNxaVVVQWdnS0Nla2lzSF92LVByN2EwU3dxcmRTZ0F3ZXRxZC1ja0hlYXdERUdEV3otTExrWGU0MExvX2Js?oc=5","date":"2025-07-09","type":"pipeline","source":"MarketWatch","summary":"Merck dives into COPD treatments with $10 billion purchase of Verona Pharma - MarketWatch","headline":"Merck dives into COPD treatments with $10 billion purchase of Verona Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQWldEVnlwSEFZUGlPMFpjSzNFeDQyNlRFQUlZVVhSb0ZOTGctUnBRZndMZ21Zb1oxVFBqSjdKVnlaM2RfY2xtVkN2M1JfbjJaVUtFUENVVzJJcXA5UWhXVG9xV3dmbUN0Ymg4X0ZwVmhwTUVJUnBiTmM2aUpTMDNYVzc5Tmt2dlg1UnBsVE8zQjlraXplY25R?oc=5","date":"2025-07-09","type":"deal","source":"London Stock Exchange","summary":"Merck to acquire Verona Pharma - 07:00:08 09 Jul 2025 - RTW News article - London Stock Exchange","headline":"Merck to acquire Verona Pharma - 07:00:08 09 Jul 2025 - RTW News article","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE0zVHJtRzk2WVZTZDM1Qm5ldEFRMnBjVko3d1pzaUJEcTNycGtIWG9iQkxxVUtNa3ZNb3JoZENMQjVIUUxrdkRiSHIycnhiR0taeTFUd0xCRDRKengzdlR1SUtTRVRCaGFRX2tXLQ?oc=5","date":"2025-07-09","type":"deal","source":"NJBIZ","summary":"Merck to acquire Verona Pharma in $10B COPD drug deal - NJBIZ","headline":"Merck to acquire Verona Pharma in $10B COPD drug deal","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-07-09","type":"deal","source":"businesswire.com","summary":"Merck to Acquire Verona Pharma, Expanding its Portfolio to Include Ohtuvayre® (ensifentrine), a First-In-Class COPD Maintenance Treatment for Adults and Expected to Drive Growth into the Next Decade -","headline":"Merck to Acquire Verona Pharma, Expanding its Portfolio to Include Ohtuvayre® (ensifentrine), a First-In-Class COPD Main","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_2":2,"marketed":1},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}